{
    "2018-03-09": [
        [
            {
                "time": "2018-01-03",
                "original_text": "FDA Approves Arm Indication for Medtronic’s Guardian Sensor 3",
                "features": {
                    "keywords": [
                        "FDA",
                        "Approves",
                        "Medtronic",
                        "Guardian Sensor 3"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Medtronic Strengthens Diabetes Business with MiniMed Infusion Set",
                "features": {
                    "keywords": [
                        "Medtronic",
                        "Diabetes",
                        "MiniMed",
                        "Infusion Set"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "An Updated Technical Strategy on Johnson & Johnson",
                "features": {
                    "keywords": [
                        "Technical Strategy",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Is Big Pharma Using Corporate Tax Savings to Lower Drug Costs?",
                "features": {
                    "keywords": [
                        "Big Pharma",
                        "Corporate Tax",
                        "Drug Costs"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Pharma Stock Roundup: MRK Signs New Cancer Deal, DERM's Acne Candidate Fails",
                "features": {
                    "keywords": [
                        "MRK",
                        "Cancer Deal",
                        "DERM",
                        "Acne Candidate"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Stocks to Watch: Qualcomm, Netflix, Tesla, Chesapeake, Wynn, J&J, GM, Mattel, Big Lots, Finisar",
                "features": {
                    "keywords": [
                        "Qualcomm",
                        "Netflix",
                        "Tesla",
                        "J&J",
                        "GM"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "entertainment",
                        "automotive",
                        "healthcare",
                        "retail"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Today’s Research Reports on Stocks to Watch: Johnson & Johnson and InVivo Therapeutics",
                "features": {
                    "keywords": [
                        "Research Reports",
                        "Johnson & Johnson",
                        "InVivo Therapeutics"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "[$$] Johnson & Johnson Says Discounts Cut the Prices for Its Drugs, Though Revenue Rose",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Discounts",
                        "Prices",
                        "Revenue"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}